| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.4M | $4.5M | $7.2M |
| YoY Revenue Growth % | -1.9% | -37.2% | — |
| Gross Profit | -$1.7M | -$417.9K | — |
| Gross Margin % | -38.7% | -9.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$5.2M | -$3.6M | -$15.4M |
| Operating Margin % | -80.0% | -79.1% | -80.0% |
| Net Income (GAAP) | -$17.4M | -$3.4M | $0 |
| EBITDA (Normalized) | -$5.2M | -$3.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$44.9M | -$2.5M | -$8.3M |
| Capital Expenditures (CapEx) | $16.8K | $40.8K | — |
| Free Cash Flow (FCF) | -$45.0M | -$2.6M | -$8.3M |
| FCF Margin % | -80.0% | -56.8% | -80.0% |
| Return on Invested Capital (ROIC %) | -20.5% | -45.0% | — |
| Cash & Short-Term Equivalents | $1.8M | $30.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $21.9M | $20.0M | — |